LH · News · 20260809N
Net Income and Profitability
LABCORP HOLDINGS INC. · 2026-08-09 · Importance 42 · Surprise 40
Labcorp’s Q2 2026 adjusted EPS rose 14.9% year over year. Operational efficiencies in both Diagnostics and Biopharma Laboratory Services supported the earnings increase. Labcorp raised its full-year 2026 adjusted EPS guidance alongside its revenue-growth outlook.
Key facts
- Q2 2026 adjusted EPS was up 14.9%. source